Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypogonadotropic hypogonadism.

Lawrence C Layman1

  • 1Department of Obstetrics and Gynecology, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912, USA. llayman@mcg.edu

Endocrinology and Metabolism Clinics of North America
|June 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in cardiovascular disease risk in type 1 diabetes: The vascular bed paradox in women.

Diabetes & vascular disease research·2026
Same author

Genetics in Reproduction.

Seminars in reproductive medicine·2026
Same author

Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening.

Seminars in reproductive medicine·2026
Same author

Clinical Testing for Genetic Conditions.

Seminars in reproductive medicine·2026
Same author

Mosaic variants in the LIM homeobox 1 (LHX1) gene contribute to Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.

Human genetics·2026
Same author

Overestimation of Pathogenic Variants in Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Idiopathic hypogonadotropic hypogonadism (IHH) in males is linked to genetic mutations affecting GnRH neuron development. Treatment options include testosterone or gonadotropin therapy to restore fertility.

Area of Science:

  • Neuroendocrinology
  • Genetics
  • Reproductive Medicine

Background:

  • Gonadotropin-releasing hormone (GnRH) and olfactory neurons share a developmental origin from the olfactory placode.
  • GnRH neurons migrate to the hypothalamus, regulating reproductive functions.
  • Idiopathic hypogonadotropic hypogonadism (IHH) presents as low testosterone and gonadotropin levels, often diagnosed late.

Purpose of the Study:

  • To summarize the genetic basis and clinical management of idiopathic hypogonadotropic hypogonadism (IHH).
  • To highlight the migratory pathway of GnRH neurons and their role in male reproductive health.

Main Methods:

  • Review of genetic mutations associated with IHH, including KAL1, FGFR1, and GNRHR.
  • Analysis of diagnostic criteria and treatment strategies for IHH in male infants and children.

Related Experiment Videos

Main Results:

  • Mutations in KAL1, FGFR1, and GNRHR are the primary genetic causes of IHH.
  • Early diagnosis in infants is challenging; diagnosis often occurs at puberty.
  • Treatment decisions depend on fertility goals: testosterone for non-fertility, GnRH/gonadotropins for fertility.

Conclusions:

  • Understanding the genetic etiology of IHH is crucial for diagnosis and management.
  • Targeted therapies can restore hormonal balance and fertility in individuals with IHH.